This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics


  • 00
  • 00
  • 00
  • 00
May 14-17, 2024 | In-Person + Digital
Boston, MA, USAHynes Convention Center

Rakhee Vatsa, Ph.D.
Scientific Officer D, Radiopharmacist at Tata Memorial Centre


Rakhee Vatsa is a Scientific Officer D (Radiopharmacist) at Advanced Centre for Treatment, Research, and Education in Cancer (ACTREC), Tata Memorial Centre, Navi Mumbai, India. After completing her post-graduation (2011) in Nuclear Medicine, she started her career as a Junior demonstrator in the Department of Nuclear Medicine, PGIMER, Chandigarh, India. The application of radiotracers inspired her for her doctoral research (2012-2016). From 2011-2021 she worked in various academic (junior, senior demonstrator) and research (research assistant and fellow) positions at PGIMER. These years have added to her the valuable knowledge for handling radioisotopes ( 99mTc, 13N, 18F, 68Ga, 177Lu, 188Re, 225Ac, and 90Y), radiolabeling and quality control procedures. She was actively involved in research and teaching programs taking lectures and practicals for postgraduate students (MSc and MD). Currently, she is part of the team establishing India’s most extensive standalone nuclear medicine facility with 41 isolation beds for high dose radioiodine therapy, radio-pharmacy, SPECT/CT, PET/CT, PET/MR and preclinical research laboratory.

Agenda Sessions

  • RGD Peptide as a Theranostic Radiotracer Targeting 𝜶vβ3 Integrin